ArticleHeliyon2024
The power of graphs in medicine: Introducing BioGraphSum for effective text summarization.
Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In biomedicine, the expansive scientific literature combined with the frequent use of abbreviations, acronyms, and symbols presents considerable challenges for text processing and summarization. The Unified Medical Language System (UMLS) has been a go-to for extracting concepts and determining correlations in these studies; hence, the BioGraphSum model introduced in this study aims to reduce this UMLS dependence. Through adoption of an innovative perspective, sentences within a piece of text are graphically conceptualized as nodes, enabling the concept of "Malatya centrality" to be leveraged. This approach focuses on pinpointing influential nodes on a graph and, by analogy, the most pertinent sentences within the text for summarization. In order to evaluate the performance of the BioGraphSum approach, a corpus was curated that consisted of 450 contemporary scientific research articles available on the PubMed database, aligned with proven research methodology. The BioGraphSum model was subjected to rigorous testing against this corpus in order to demonstrate its capabilities. Preliminary results, especially in the precision-based and f-score-based ROUGE-(1-2), ROUGE-L, and ROUGE-SU metrics reported significant improvements when compared to other existing models considered state-of-the-art in text summarization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.